Health Condition 1: H401- Open-angle glaucoma
Conditions
Interventions
Intervention1: Netarsudil 0.02% ophthalmic solution: we will administer 1 drop of Netarsudil 0.02% ophthalmic solution through topical self administration once at bed time in patients of primary angle
Sponsors
Maharaja agrasen medical college
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1. Patients of either sex of age > 40 years. 2. Clinically diagnosed patients of: Primary angle closure glaucoma 3. Able to give informed consent and follow study instructions
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1 Patients having known hypersensitivity to any component of the formulation. 2 Previous glaucoma surgery or refractive surgery. 3 Report of ocular injury in either eye. 4 Inability to come for regular follow up. 5 Ocular diseases with inflammation as a manifestation. 6 Use of systemic medication (steroids) that could affect the IOP.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of Intra Ocular Pressure from baseline.Timepoint: Reduction of Intra Ocular Pressure from baseline at 15 days, 1 month 2 months and 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| To report the proportion of adverse drug reaction by using naranjo scale.Timepoint: 15 days, 1 month, 2 months, 3 months & 6 months after drug administration | — |
Countries
India
Contacts
Public ContactDr Anshul Yadav
maharaja agrasen medical college agroha hisar
Outcome results
None listed